Skip to main content
Advertisement

< Back to Article

Fig 1.

Participant progress flow during data collection procedure.

More »

Fig 1 Expand

Fig 2.

Distribution of the study population according to gender and age groups.

More »

Fig 2 Expand

Table 1.

Mf prevalences in the communities prospected during the 1998-2002 and 2020 epidemiological surveys conducted in Adamaoua Region.

More »

Table 1 Expand

Table 2.

Microfilaria and nodule prevalences recorded in the health districts of the Adamaoua Region.

More »

Table 2 Expand

Fig 3.

Nodule (A) and microfilaria (B) prevalences recorded in the surveyed Health Districts.

More »

Fig 3 Expand

Fig 4.

Trend in microfilaria prevalence in 22 communities surveyed in the 1998-2002 baseline and the 2020 follow-up surveys in the Adamaoua Region.

More »

Fig 4 Expand

Fig 5.

Therapeutic coverage rates reported (Red dot) and surveyed (histogram bar) in 2019 in the health districts of Adamaoua Region.

More »

Fig 5 Expand

Fig 6.

Population adherence to ivermectin treatment rates by gender during the 2019 mass distribution in the 9 health districts of Adamaoua Region.

More »

Fig 6 Expand

Fig 7.

Population adherence rates according to age groups during the 2019 ivermectin mass treatment in the 9 health districts of Adamaoua Region.

More »

Fig 7 Expand